Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

Clinical trial NCT05983770 · COMPLETED

Trial details

NCT number: NCT05983770
Sponsor: Eledon Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Kidney Transplant Rejection

Start date: 2023-08-30
Primary completion: 2025-09-11
Enrollment: 127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.